Yayın:
<i>N</i>‐Substituted Arylidene‐3‐(Methylsulfonyl)‐2‐Oxoimidazolidine‐1‐Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study

dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.authorBedia Koçyiğit‐Kaymakçıoğlu
dc.contributor.orcid0000-0002-4569-008X
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0001-8815-153X
dc.contributor.orcid0000-0003-2252-0923
dc.contributor.orcid0000-0003-0817-8236
dc.date.accessioned2025-11-13T10:27:01Z
dc.date.issued2022-06-28
dc.identifier.doihttps://doi.org/10.1002/cbdv.202200265
dc.identifier.endpagee202200265
dc.identifier.issn1612-1872
dc.identifier.issue8
dc.identifier.openalexW4283652049
dc.identifier.startpagee202200265
dc.identifier.urihttps://hdl.handle.net/11421/4186
dc.identifier.urihttps://doi.org/10.1002/cbdv.202200265
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofChemistry & Biodiversity
dc.rightsrestrictedAccess
dc.subjectChemistry
dc.subjectAcetylcholinesterase
dc.subjectCholinesterase
dc.subjectDocking (animal)
dc.subjectEnzyme
dc.subjectAché
dc.subjectStereochemistry
dc.subjectSubstituent
dc.subjectCarbohydrazide
dc.subjectGalantamine
dc.subjectDonepezil
dc.subjectPharmacology
dc.subjectBiochemistry
dc.subjectMedicinal chemistry
dc.subjectDementia
dc.subjectDisease
dc.subjectInternal medicine
dc.subject.sdg3
dc.title<i>N</i>‐Substituted Arylidene‐3‐(Methylsulfonyl)‐2‐Oxoimidazolidine‐1‐Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5030511747
local.authorid.openalexA5060247565
local.authorid.openalexA5074136342

Dosyalar

Koleksiyonlar